研究者
J-GLOBAL ID:201901017283955821
更新日: 2023年01月21日
廣田 聡
ヒロタ アキラ | HIROTA Akira
競争的資金等の研究課題 (2件):
- 2021 - 2024 ES細胞・iPS細胞の機能制御を可能とする新規荷電性培養基板の開発
- 2019 - 2021 合成ハイドロゲルによるES/iPS細胞機能制御の開発
論文 (4件):
-
Akira Hirota, Jean-Emmanuel Clément, Satoshi Tanikawa, Takayuki Nonoyama, Tamiki Komatsuzaki, Jian Ping Gong, Shinya Tanaka, Masamichi Imajo. ERK MAP Kinase Signaling Regulates RAR Signaling to Confer Retinoid Resistance on Breast Cancer Cells. Cancers. 2022. 14. 23. 5890-5890
-
Hirota, A., AlMusawi, S., Nateri, A.S., Ordóñez-Morán, P., Imajo, M. Biomaterials for intestinal organoid technology and personalized disease modeling. Acta Biomaterialia. 2021. 132
-
Hirota, A., Nakajima-Koyama, M., Ashida, Y., Nishida, E. The nucleosome remodeling and deacetylase complex protein CHD4 regulates neural differentiation of mouse embryonic stem cells by down-regulating p53. Journal of Biological Chemistry. 2019. 294. 1. 195-209
-
Ashida, Y., Nakajima-Koyama, M., Hirota, A., Yamamoto, T., Nishida, E. Activin A in combination with ERK1/2 MAPK pathway inhibition sustains propagation of mouse embryonic stem cells. Genes to Cells. 2017. 22. 2. 189-202
前のページに戻る